… the major driver of the thyroid cancer “epidemic”. Papillary thyroid carcinoma, usually with
… We aimed to identify clinicopathological factors associated with papillary thyroid carcinoma …

… poor. The objectives of this study were to identify clinical and molecular factors of poor … In
conclusion, we confirmed that poorly differentiated thyroid carcinomas have a dismal prognosis …

… not by themselves impart poor outcome and are not sufficient … an intermediate prognosis
in thyroid carcinomas. We use … fluorodeoxyglucose-PET-positive thyroid carcinoma (16), …

… We retrospectively analyzed whether poor differentiation is the independent prognostic factor
for thyroid carcinoma or not. Methods. The subjects were 29 patients with PDTC who were …

… The overexpression of HER1 has been shown to confer a poor prognosis to thyroid carcinomas
[16]. HER2 is overexpressed in ATCs [29]. Four distinct fibroblast growth factor receptor (…

… cancer syndromes, early diagnosis and intervention based on genetic testing might
prevent poor disease outcomes. Care should be carefully coordinated by members of an …

… systems for well-differentiated thyroid carcinoma (WDTC) are well known. The development
of disease recurrence is associated with a poor outcome; however, the prognostic …

Background The objective of this study is to perform a meta-analysis to evaluate the associations
between the BRAF V600E mutation status and aggressive clinicopathological features …

… thyroid carcinomas analyzed to date display telomerase activation that is more frequent in
undifferentiated thyroid carcinomas than in differentiated carcinomas … to the thyroid carcinoma (…

… poorer outcomes. Differentiated thyroid carcinoma is one of the most curable cancers; but …
disease develops in 7% to 23% of patients with differentiated thyroid cancer1, 2, 3, 4, 5 and …